156 related articles for article (PubMed ID: 1631729)
21. [Seroepidemiologic study of measles in 2 populations of children under 10 years of age from the metropolitan area].
Ramírez E; Espiñeira E
Rev Med Chil; 1992 May; 120(5):589-92. PubMed ID: 1343074
[TBL] [Abstract][Full Text] [Related]
22. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
23. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
24. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
Yu X; Wang S; Guan J; Mahemuti ; Purhati ; Gou A; Liu Q; Jin X; Ghildyal R
Pediatr Infect Dis J; 2007 Jun; 26(6):513-8. PubMed ID: 17529869
[TBL] [Abstract][Full Text] [Related]
27. Experience with a measles vaccine manufactured in India.
Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
[TBL] [Abstract][Full Text] [Related]
28. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
29. [Seroepidemiology of whooping cough in Mexico].
Sapián-López LA; Valdespino JL; Salvatierra B; Tapia-Conyer R; Gutiérrez G; Macedo J; Sepúlveda J
Salud Publica Mex; 1992; 34(2):177-85. PubMed ID: 1631731
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
[TBL] [Abstract][Full Text] [Related]
31. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
[TBL] [Abstract][Full Text] [Related]
32. Impact of mass measles campaigns among children less than 5 years old in Uganda.
Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
[TBL] [Abstract][Full Text] [Related]
33. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
34. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
Cutts FT; Monteiro O; Tabard P; Cliff J
Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
[TBL] [Abstract][Full Text] [Related]
35. [The national addictions survey of Mexico].
Tapia-Conyer R; Medina-Mora ME; Sepúlveda J; De la Fuente R; Kumate J
Salud Publica Mex; 1990; 32(5):507-22. PubMed ID: 2089626
[TBL] [Abstract][Full Text] [Related]
36. [Seroepidemiology of brucellosis in Mexico].
López-Merino A; Migranas-Ortiz R; Pérez-Miravete A; Magos C; Salvatierra-Izaba B; Tapia-Conyer R; Valdespino JL; Sepúlveda J
Salud Publica Mex; 1992; 34(2):230-40. PubMed ID: 1631736
[TBL] [Abstract][Full Text] [Related]
37. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
38. [Determining factors of rubella in the 10 to 14 year-old population in Mexico].
Tapia-Conyer R; Sepúlveda J; Salvatierra B; Muńoz O; Bustamante-Calvillo E; Alvarez y Muńoz T; Gutiérrez G
Salud Publica Mex; 1992; 34(2):211-21. PubMed ID: 1631734
[TBL] [Abstract][Full Text] [Related]
39. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of placentally transmitted antibodies for measles in infants 3 to 11 months old in an urban slum community.
Deivanayagam N; Vasudevan S; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
Indian Pediatr; 1990 Sep; 27(9):919-23. PubMed ID: 2286435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
